Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC

Journal of Molecular Biology

Volumn 290, Issue 1, 1999, Pages 149-159

  Ultsch, Mark H ^b   Wiesmann, Christian ^b   Simmons, Laura C ^b   Henrich, Jill ^b   Yang, Maria ^b   Reilly, Dorothea ^a   Bass, Steven H ^b   De Vos, Abraham M ^b  

^a GENENTECH INC   (United States)

^b NONE

Author keywords

3D domain swapping; Ligand binding site; Receptor tyrosine kinase; Specificity; Trk receptors

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN; TYROSINE KINASE RECEPTOR;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; DISULFIDE BOND; MOLECULAR MODEL; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING;

EID: 0033516607     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2816     Document Type: Article

References (49)

1. Barbacid M. The Trk family of neurotrophin receptors. J. Neurobiol. 25:1994;1386-1403.
2. Barker P. A., Lomen-Hoerth C., Gensch E. M., Meakin S. O., Glass D. J., Shooter E. M. Tissue-specific alternative splicing generates two isoforms of the trkA receptor. J. Biol. Chem. 268:1993;15150-15157.
3. Bass S., Yang M. Expressing cloned genes in Escherichia coli. Creighton T. E. Protein Function: A Practical Approach. 1997;29-55 Oxford University Press, Oxford.
4. Bennett M. J., Choe S., Eisenberg D. Refined structure of dimeric diphtheria toxin at 2.0 A resolution. Protein Sci. 3:1994;1444-1463.
5. Berkemeier L. R., Winslow J. W., Kaplan D. R., Nikolics K., Goeddel D. V., Rosenthal A. Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron. 7:1991;857-866.
6. Bradshaw R. A., Murray-Rust J., Ibanez C. F., McDonald N. Q., Lapatto R., Blundell T. L. Nerve growth factor: structure/function relationships. Protein Sci. 3:1994;1901-1913.
7. Brünger A. T. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature. 355:1992;472-475.
8. Brünger A. T., Kuriyan J., Karplus M. Crystallographic R factor refinement by molecular dynamics. Science. 235:1987;458-460.
9. CCP4. Programs for protein crystallography. Acta Crystallog. sect. D. 50:1994;760-763.
10. Chang C. N., Rey M., Bochner B., Heyneker H., Gray G. High-level secretion of human growth hormone by Escherichia coli. Gene. 55:1987;189-196.
11. Chothia C., Jones E. Y. The molecular structure of cell adhesion molecules. Annu. Rev. Biochem. 66:1997;823-862.
12. Clement J. M., Hofnung M. Gene sequence of the lambda receptor, an outer membrane protein of E. coli K12. Cell. 27:1981;507-514.
13. Cordon-Cardo C., Tapley P., Jing S. Q., Nanduri V., O'Rourke E., Lamballe F., Kovary K., Klein R., Jones K. R., Reichardt L. F., Barbacid M. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell. 66:1991;173-183.
14. Dechant G., Barde Y. A. Signalling through the neurotrophin receptor p75NTR. Curr. Opin. Neurobiol. 7:1997;413-418.
15. Frade J. M., Barde Y. A. Nerve growth factor: two receptors, multiple functions. BioEssays. 20:1998;137-145.
16. Götz R., Köster R., Winkler C., Raulf F., Lottspeich F., Schartl M., Thoenen H. Neurotrophin-6 is a new member of the nerve growth factor family. Nature. 372:1994;266-269.
17. Harpaz Y., Chothia C. Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. J. Mol. Biol. 238:1994;528-539.
18. Holden H. M., Ito M., Hartshorne D. J., Rayment I. X-ray structure determination of telokin, the C-terminal domain of myosin light chain kinase, at 2.8 Å resolution. J. Mol. Biol. 227:1992;840-851.
19. Holden P. H., Asopa V., Robertson A. G., Clarke A. R., Tyler S., Bennett G. S., Brain S. D., Wilcock G. K., Allen S. J., Smith S. K., Dawbarn D. Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor. Nature Biotechnol. 15:1997;668-672.
20. Ibá ñ C. F., Ebendal T., Barbany G., Murray-Rust J., Blundell T. L., Persson H. Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell. 69:1992;329-341.
21. Ibá ñ C. F., Ilag L. L., Murray-Rust J., Persson H. An extended surface of binding to Trk tyrosine kinase receptors in NGF and BDNF allows the engineering of a multifunctional pan-neurotrophin. EMBO J. 12:1993;2281-2293.
22. Ip N. Y., Ibanez C. F., Nye S. H., McClain J., Jones P. F., Gies D. R., Belluscio L., Le Beau M. M., Espinosa R. d., Squinto S. P. et al. Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc. Natl Acad. Sci. USA. 89:1992;3060-3064.
23. Jones E. Y., Harlos K., Bottomley M. J., Robinson R. C., Driscoll P. C., Edwards R. M., Clements J. M., Dudgeon T. J., Stuart D. I. Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 Å resolution. Nature. 373:1995;539-544.
24. Jones T. A., Zou J.-Y., Cowan S. W., Kjelgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A. 47:1991;110-119.
25. Kaplan D. R., Hempstead B. L., Martin-Zanca D., Chao M. V., Parada L. F. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science. 252:1991;554-558.
26. Klein R., Parada L. F., Coulier F., Barbacid M. trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development. EMBO J. 8:1989;3701-3709.
27. Klein R., Jing S. Q., Nanduri V., O'Rourke E., Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell. 65:1991a;189-197.
28. Klein R., Nanduri V., Jing S. A., Lamballe F., Tapley P., Bryant S., Cordon-Cardo C., Jones K. R., Reichardt L. F., Barbacid M. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell. 66:1991b;395-403.
29. Lai K. O., Fu W. Y., Ip F. C., Ip N. Y. Cloning and expression of a novel neurotrophin, NT-7, from carp. Mol. Cell. Neurosci. 11:1998;64-76.
30. Lamballe F., Klein R., Barbacid M. trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell. 66:1991;967-979.
31. Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M. Procheck: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26:1993;283-291.
32. Martin-Zanca D., Oskam R., Mitra G., Copeland T., Barbacid M. Molecular and biochemical characterization of the human trk proto-oncogene. Mol. Cell. Biol. 9:1989;24-33.
33. McDonald N. Q., Lapatto R., Murray-Rust J., Gunning J., Wlodawer A., Blundell T. L. New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor. Nature. 354:1991;411-414.
34. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 176:1997;307-326.
35. Pérez P., Coll P. M., Hempstead B. L., Martin-Zanca D., Chao M. V. NGF binding to the trk tyrosine kinase receptor requires the extracellular immunoglobulin-like domains. Mol. Cell. Neurosci. 6:1995;97-105.
36. Schlessinger J., Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron. 9:1992;383-391.
37. Schlunegger M. P., Bennett M. J., Eisenberg D. Oligomer formation by 3D domain swapping: a model for protein assembly and misassembly. Advan. Protein Chem. 50:1997;61-122.
38. Schneider R., Schweiger M. A novel modular mosaic of cell adhesion motifs in the extracellular domains of the neurogenic trk and trkB tyrosine kinase receptors. Oncogene. 6:1991;1807-1811.
39. Shelton D. L., Sutherland J., Gripp J., Camerato T., Armanini M. P., Phillips H. S., Carroll K., Spencer S. D., Levinson A. D. Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins. J. Neurosci. 15:1995;477-491.
40. Shih A., Laramee G. R., Schmelzer C. H., Burton L. E., Winslow J. W. Mutagenesis identifies amino-terminal residues of nerve growth factor necessary for Trk receptor binding and biological activity. J. Biol. Chem. 269:1994;27679-27686.
41. Simmons L. C., Yansura D. G. Translational level is a critical factor for the secretion of heterologous proteins in Escherichia coli. Nature Biotechnol. 14:1996;629-634.
42. Snider W. D. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell. 77:1994;627-638.
43. Soppet D., Escandon E., Maragos J., Middlemas D. S., Reid S. W., Blair J., Burton L. E., Stanton B. R., Kaplan D. R., Hunter T. et al. The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell. 65:1991;895-903.
44. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
45. Urfer R., Tsoulfas P., Soppet D., Escandon E., Parada L. F., Presta L. G. The binding epitopes of neurotrophin-3 to its receptors trkC and gp75 and the design of a multifunctional human neurotrophin. EMBO J. 13:1994;5896-5909.
46. Urfer R., Tsoulfas P., O'Connell L., Shelton D. L., Parada L. F., Presta L. G. An immunoglobulin-like domain determines the specificity of neurotrophin receptors. EMBO J. 14:1995;2795-2805.
47. Urfer R., Tsoulfas P., O'Connell L., Presta L. G. Specificity determinants in neurotrophin-3 and design of nerve growth factor-based trkC agonists by changing central beta-strand bundle residues to their neurotrophin-3 analogs. Biochemistry. 36:1997;4775-4781.
48. Urfer R., Tsoulfas P., O'Connell L., Hongo J. A., Zhao W., Presta L. G. High resolution mapping of the binding site of TrkA for nerve growth factor and TrkC for neurotrophin-3 on the second immunoglobulin-like domain of the Trk receptors. J. Biol. Chem. 273:1998;5829-5840.
49. Wiesmann C., Fuh G., Christinger H. W., Eigenbrot C., Wells J. A., de Vos A. M. Crystal structure at 1. 7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell. 91:1?997;695-704.